Wikidata

(Q27853023)

English

Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations

scientific article

In more languages

Statements

title
Phase I expansion and pharmacodynamic study of the oral MEK inhibitor RO4987655 (CH4987655) in selected patients with advanced cancer with RAS-RAF mutations (English)
1 reference
stated in
PubMed
PubMed publication ID
24947927
retrieved
13 November 2016
author
Françoise Kraeber-Bodéré
series ordinal
13
object named as
Françoise Kraeber-Bodéré
0 references
Jean-Charles Soria
series ordinal
19
object named as
Jean-Charles Soria
0 references
author name string
Lisa Zimmer
series ordinal
1
0 references
Fabrice Barlesi
series ordinal
2
0 references
Maria Martinez-Garcia
series ordinal
3
0 references
Veronique Dieras
series ordinal
4
0 references
Jan H M Schellens
series ordinal
5
0 references
Jean-Philippe Spano
series ordinal
6
0 references
Mark R Middleton
series ordinal
7
0 references
Emiliano Calvo
series ordinal
8
0 references
Luiz Paz-Ares
series ordinal
9
0 references
James Larkin
series ordinal
10
0 references
Simon Pacey
series ordinal
11
0 references
Miro Venturi
series ordinal
12
0 references
Jean J L Tessier
series ordinal
14
0 references
Wilfried Ernst Erich Eberhardt
series ordinal
15
0 references
Michel Paques
series ordinal
16
0 references
Ernesto Guarin
series ordinal
17
0 references
Valerie Meresse
series ordinal
18
0 references
publication date
15 August 2014
0 references
volume
20
0 references
issue
16
0 references
page(s)
4251-61
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q27853023&oldid=1445863450"